Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|September 3, 2019
ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitorsNazmul H Bhuiyan, Michelle L Varney, Deep S Bhattacharya, et al.
Leukemia & Lymphoma|April 14, 2016
Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 statusHesham M Hassan, Michelle L Varney, Nagendra K Chaturvedi, et al.
Cancer Science|November 29, 2008
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activationMitsuru Futakuchi, Kalyan C Nannuru, Michelle L Varney, et al.
Bioorganic & Medicinal Chemistry|July 23, 2021
Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitorsAlisa E R Fairweather, Daniel B Goetz, Chloe M Schroeder, et al.
Oncotarget|February 22, 2018
Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasisSugandha Saxena, Yuri Hayashi, Lingyun Wu, et al.
International Journal of Cancer|January 15, 2010
High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasisAnguraj Sadanandam, Michelle L Varney, Seema Singh, et al.
Clinical & Experimental Metastasis|July 11, 2009
Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysisKalyan C Nannuru, Mitsuru Futakuchi, Anguraj Sadanandam, et al.
Drug Development Research|November 26, 2022
Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcomaStaci L Haney, Dan Feng, Yashpal S Chhonker, et al.
Drug Development Research|November 14, 2023
Investigation of the activity of a novel tropolone in osteosarcomaStaci L Haney, Dan Feng, Sai Sundeep Kollala, et al.
Toxicology and Applied Pharmacology|March 17, 2009
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouseSatoko Kakiuchi-Kiyota, Joseph A Vetro, Shugo Suzuki, et al.
Pageof 6